USPTO serial 90843027
MEDPOINT DIGITAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 4, 2022
- Examiner
- CERDA, VICTOR
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MEDPOINT DIGITAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John L. Ambrogi
John L. Ambrogi LATIMER LEVAY FYOCK LLC55 WEST MONROE STREETSUITE 1100CHICAGO, IL 60603Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Training and support services, namely, providing courses of instruction in the field of digital media support for clinical research via live digital training events, non-downloadable, website-based training modules, and a non-downloadable, website-based training management center; training clinical research raters in the use of digital and web site-based systems; on-line journals, namely, blogs featuring instruction in the field of digital media support for clinical research; education services, namely, providing nondownloadable webinars and videos in the field of digital media support for clinical research | ACTIVE | — |
| 042 | Providing digital technology services, namely, software as a service (SAAS) services featuring a software platform for providing users access to documents, training, messages, alerts, forms, and related materials in the fields of medical and scientific research information and clinical trials; web-based computer services, namely, a web-based system in the nature of providing online non-downloadable software for providing users access to documents, training, messages, alerts, forms, and related materials in the fields of medical and scientific research information and clinical trials; providing medical and scientific research information in the field of clinical trials via an online web-based community portal; hosting secure, audit-ready compliant online web facilities for others for organizing and conducting online meetings, gatherings, and interactive discussions for the biopharma industry; providing a website featuring technology that enables clinical research associate users to monitor investigative sites that are conducting clinical trials by means of live virtual meetings; providing an online non-downloadable software platform for conducting live virtual meetings that enable remote, digital patient visits to investigator sites in the course of clinical trials for medicines and medical products; providing a website featuring technology that enables health care professional speakers to hold digital online meetings for virtual events over the internet; providing a website featuring technology that enables users to hold virtual speaking events and webcasts; providing a website featuring technology that enables health care professionals to conduct virtual and online digital advisory and consulting meetings; providing a website featuring technology that enables users to conduct virtual and online digital pharmaceutical and biotech training events; providing online non-downloadable computer software for document management to medical product companies, pharmaceutical companies, and biotechnology companies; providing online non-downloadable computer software enabling access to an internet website portal that provides patients with information regarding clinical trials and allows them to stay connected and in control of their role as participants in clinical trials; computer programming; customizing computer software; computer system analysis and computer design for medical product companies, pharmaceutical companies, and biotechnology companies in the field of document management processes relating to product marketing, commercialization, medical affairs and clinical research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Medpoint Communications, Inc.
- Other trademarks owned by Medpoint Communications, Inc.
- Other trademarks owned by Medpoint Communications, Inc.
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named MEDPOINT DIGITAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 4, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 29, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 16, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 15, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 15, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 3, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 17, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |